Advanced search
Publication Cover
Acta Chirurgica Belgica Volume 106, 2006 - Issue 2
Submit an article Journal homepage
17
Views
20
CrossRef citations to date
0
Altmetric
Review Papers

Survival of Rectal Cancer Patients in Belgium 1997–98 and the Potential Benefit of a National Project

F. Penninckx The PROCARE working group consists of delegates from all Belgian scientific organisations involved in the treatment of rectum cancer, i.e. the Belgian Section of Colorectal Surgery, a section of the Royal Belgian Society of Surgery (De Coninck D., Duinslaeger M., Kartheuser A., Penninckx F., Van de Stadt J., Vaneerdeweg W.), the Belgian Society of Surgical Oncology (Claeys D.), the Belgian Group for Endoscopic Surgery (Burnon D.), the Belgian Society of Radiotherapy — Oncology (Haustermans K., Scalliet P., Spaas Ph.), the Belgian Society of Pathology and the Digestive Pathology Club (Ectors N., Jouret A.), the Belgian Society of Medical Oncology (Bleiberg H., Humblet Y., Van Cutsem E.), the Belgian Group for Digestive Oncology (Laurent S., Van Cutsem E., Van Laethem J. L.), the Royal Belgian Society of Radiology (Op de Beeck B., Danse E.), the Société Royale Belge de Gastro-entérologie (Melange M., Rahier J.), the Vlaamse Vereniging voor Gastro-enterologie (Cabooter M., Pattyn P., Peeters M.), the Belgian Society of Gastro-intestinal Endoscopy (Buset M.). Are also represented: the Belgian Professional Surgical Association (Haeck L., Mansvelt B.), the Private Foundation Belgian Cancer Registry (Van Eycken E.). Penninckx F. chairs the PROCARE Workgroup.View further author information
,
L. Van Eycken The PROCARE working group consists of delegates from all Belgian scientific organisations involved in the treatment of rectum cancer, i.e. the Belgian Section of Colorectal Surgery, a section of the Royal Belgian Society of Surgery (De Coninck D., Duinslaeger M., Kartheuser A., Penninckx F., Van de Stadt J., Vaneerdeweg W.), the Belgian Society of Surgical Oncology (Claeys D.), the Belgian Group for Endoscopic Surgery (Burnon D.), the Belgian Society of Radiotherapy — Oncology (Haustermans K., Scalliet P., Spaas Ph.), the Belgian Society of Pathology and the Digestive Pathology Club (Ectors N., Jouret A.), the Belgian Society of Medical Oncology (Bleiberg H., Humblet Y., Van Cutsem E.), the Belgian Group for Digestive Oncology (Laurent S., Van Cutsem E., Van Laethem J. L.), the Royal Belgian Society of Radiology (Op de Beeck B., Danse E.), the Société Royale Belge de Gastro-entérologie (Melange M., Rahier J.), the Vlaamse Vereniging voor Gastro-enterologie (Cabooter M., Pattyn P., Peeters M.), the Belgian Society of Gastro-intestinal Endoscopy (Buset M.). Are also represented: the Belgian Professional Surgical Association (Haeck L., Mansvelt B.), the Private Foundation Belgian Cancer Registry (Van Eycken E.). Penninckx F. chairs the PROCARE Workgroup.
,
G. Michiels The PROCARE working group consists of delegates from all Belgian scientific organisations involved in the treatment of rectum cancer, i.e. the Belgian Section of Colorectal Surgery, a section of the Royal Belgian Society of Surgery (De Coninck D., Duinslaeger M., Kartheuser A., Penninckx F., Van de Stadt J., Vaneerdeweg W.), the Belgian Society of Surgical Oncology (Claeys D.), the Belgian Group for Endoscopic Surgery (Burnon D.), the Belgian Society of Radiotherapy — Oncology (Haustermans K., Scalliet P., Spaas Ph.), the Belgian Society of Pathology and the Digestive Pathology Club (Ectors N., Jouret A.), the Belgian Society of Medical Oncology (Bleiberg H., Humblet Y., Van Cutsem E.), the Belgian Group for Digestive Oncology (Laurent S., Van Cutsem E., Van Laethem J. L.), the Royal Belgian Society of Radiology (Op de Beeck B., Danse E.), the Société Royale Belge de Gastro-entérologie (Melange M., Rahier J.), the Vlaamse Vereniging voor Gastro-enterologie (Cabooter M., Pattyn P., Peeters M.), the Belgian Society of Gastro-intestinal Endoscopy (Buset M.). Are also represented: the Belgian Professional Surgical Association (Haeck L., Mansvelt B.), the Private Foundation Belgian Cancer Registry (Van Eycken E.). Penninckx F. chairs the PROCARE Workgroup.
,
R. Mertens The PROCARE working group consists of delegates from all Belgian scientific organisations involved in the treatment of rectum cancer, i.e. the Belgian Section of Colorectal Surgery, a section of the Royal Belgian Society of Surgery (De Coninck D., Duinslaeger M., Kartheuser A., Penninckx F., Van de Stadt J., Vaneerdeweg W.), the Belgian Society of Surgical Oncology (Claeys D.), the Belgian Group for Endoscopic Surgery (Burnon D.), the Belgian Society of Radiotherapy — Oncology (Haustermans K., Scalliet P., Spaas Ph.), the Belgian Society of Pathology and the Digestive Pathology Club (Ectors N., Jouret A.), the Belgian Society of Medical Oncology (Bleiberg H., Humblet Y., Van Cutsem E.), the Belgian Group for Digestive Oncology (Laurent S., Van Cutsem E., Van Laethem J. L.), the Royal Belgian Society of Radiology (Op de Beeck B., Danse E.), the Société Royale Belge de Gastro-entérologie (Melange M., Rahier J.), the Vlaamse Vereniging voor Gastro-enterologie (Cabooter M., Pattyn P., Peeters M.), the Belgian Society of Gastro-intestinal Endoscopy (Buset M.). Are also represented: the Belgian Professional Surgical Association (Haeck L., Mansvelt B.), the Private Foundation Belgian Cancer Registry (Van Eycken E.). Penninckx F. chairs the PROCARE Workgroup.
,
C. Bertrand The PROCARE working group consists of delegates from all Belgian scientific organisations involved in the treatment of rectum cancer, i.e. the Belgian Section of Colorectal Surgery, a section of the Royal Belgian Society of Surgery (De Coninck D., Duinslaeger M., Kartheuser A., Penninckx F., Van de Stadt J., Vaneerdeweg W.), the Belgian Society of Surgical Oncology (Claeys D.), the Belgian Group for Endoscopic Surgery (Burnon D.), the Belgian Society of Radiotherapy — Oncology (Haustermans K., Scalliet P., Spaas Ph.), the Belgian Society of Pathology and the Digestive Pathology Club (Ectors N., Jouret A.), the Belgian Society of Medical Oncology (Bleiberg H., Humblet Y., Van Cutsem E.), the Belgian Group for Digestive Oncology (Laurent S., Van Cutsem E., Van Laethem J. L.), the Royal Belgian Society of Radiology (Op de Beeck B., Danse E.), the Société Royale Belge de Gastro-entérologie (Melange M., Rahier J.), the Vlaamse Vereniging voor Gastro-enterologie (Cabooter M., Pattyn P., Peeters M.), the Belgian Society of Gastro-intestinal Endoscopy (Buset M.). Are also represented: the Belgian Professional Surgical Association (Haeck L., Mansvelt B.), the Private Foundation Belgian Cancer Registry (Van Eycken E.). Penninckx F. chairs the PROCARE Workgroup.
,
D. De Coninck The PROCARE working group consists of delegates from all Belgian scientific organisations involved in the treatment of rectum cancer, i.e. the Belgian Section of Colorectal Surgery, a section of the Royal Belgian Society of Surgery (De Coninck D., Duinslaeger M., Kartheuser A., Penninckx F., Van de Stadt J., Vaneerdeweg W.), the Belgian Society of Surgical Oncology (Claeys D.), the Belgian Group for Endoscopic Surgery (Burnon D.), the Belgian Society of Radiotherapy — Oncology (Haustermans K., Scalliet P., Spaas Ph.), the Belgian Society of Pathology and the Digestive Pathology Club (Ectors N., Jouret A.), the Belgian Society of Medical Oncology (Bleiberg H., Humblet Y., Van Cutsem E.), the Belgian Group for Digestive Oncology (Laurent S., Van Cutsem E., Van Laethem J. L.), the Royal Belgian Society of Radiology (Op de Beeck B., Danse E.), the Société Royale Belge de Gastro-entérologie (Melange M., Rahier J.), the Vlaamse Vereniging voor Gastro-enterologie (Cabooter M., Pattyn P., Peeters M.), the Belgian Society of Gastro-intestinal Endoscopy (Buset M.). Are also represented: the Belgian Professional Surgical Association (Haeck L., Mansvelt B.), the Private Foundation Belgian Cancer Registry (Van Eycken E.). Penninckx F. chairs the PROCARE Workgroup.
,
K. Haustermans The PROCARE working group consists of delegates from all Belgian scientific organisations involved in the treatment of rectum cancer, i.e. the Belgian Section of Colorectal Surgery, a section of the Royal Belgian Society of Surgery (De Coninck D., Duinslaeger M., Kartheuser A., Penninckx F., Van de Stadt J., Vaneerdeweg W.), the Belgian Society of Surgical Oncology (Claeys D.), the Belgian Group for Endoscopic Surgery (Burnon D.), the Belgian Society of Radiotherapy — Oncology (Haustermans K., Scalliet P., Spaas Ph.), the Belgian Society of Pathology and the Digestive Pathology Club (Ectors N., Jouret A.), the Belgian Society of Medical Oncology (Bleiberg H., Humblet Y., Van Cutsem E.), the Belgian Group for Digestive Oncology (Laurent S., Van Cutsem E., Van Laethem J. L.), the Royal Belgian Society of Radiology (Op de Beeck B., Danse E.), the Société Royale Belge de Gastro-entérologie (Melange M., Rahier J.), the Vlaamse Vereniging voor Gastro-enterologie (Cabooter M., Pattyn P., Peeters M.), the Belgian Society of Gastro-intestinal Endoscopy (Buset M.). Are also represented: the Belgian Professional Surgical Association (Haeck L., Mansvelt B.), the Private Foundation Belgian Cancer Registry (Van Eycken E.). Penninckx F. chairs the PROCARE Workgroup.
,
A. Jouret The PROCARE working group consists of delegates from all Belgian scientific organisations involved in the treatment of rectum cancer, i.e. the Belgian Section of Colorectal Surgery, a section of the Royal Belgian Society of Surgery (De Coninck D., Duinslaeger M., Kartheuser A., Penninckx F., Van de Stadt J., Vaneerdeweg W.), the Belgian Society of Surgical Oncology (Claeys D.), the Belgian Group for Endoscopic Surgery (Burnon D.), the Belgian Society of Radiotherapy — Oncology (Haustermans K., Scalliet P., Spaas Ph.), the Belgian Society of Pathology and the Digestive Pathology Club (Ectors N., Jouret A.), the Belgian Society of Medical Oncology (Bleiberg H., Humblet Y., Van Cutsem E.), the Belgian Group for Digestive Oncology (Laurent S., Van Cutsem E., Van Laethem J. L.), the Royal Belgian Society of Radiology (Op de Beeck B., Danse E.), the Société Royale Belge de Gastro-entérologie (Melange M., Rahier J.), the Vlaamse Vereniging voor Gastro-enterologie (Cabooter M., Pattyn P., Peeters M.), the Belgian Society of Gastro-intestinal Endoscopy (Buset M.). Are also represented: the Belgian Professional Surgical Association (Haeck L., Mansvelt B.), the Private Foundation Belgian Cancer Registry (Van Eycken E.). Penninckx F. chairs the PROCARE Workgroup.
,
A. Kartheuser The PROCARE working group consists of delegates from all Belgian scientific organisations involved in the treatment of rectum cancer, i.e. the Belgian Section of Colorectal Surgery, a section of the Royal Belgian Society of Surgery (De Coninck D., Duinslaeger M., Kartheuser A., Penninckx F., Van de Stadt J., Vaneerdeweg W.), the Belgian Society of Surgical Oncology (Claeys D.), the Belgian Group for Endoscopic Surgery (Burnon D.), the Belgian Society of Radiotherapy — Oncology (Haustermans K., Scalliet P., Spaas Ph.), the Belgian Society of Pathology and the Digestive Pathology Club (Ectors N., Jouret A.), the Belgian Society of Medical Oncology (Bleiberg H., Humblet Y., Van Cutsem E.), the Belgian Group for Digestive Oncology (Laurent S., Van Cutsem E., Van Laethem J. L.), the Royal Belgian Society of Radiology (Op de Beeck B., Danse E.), the Société Royale Belge de Gastro-entérologie (Melange M., Rahier J.), the Vlaamse Vereniging voor Gastro-enterologie (Cabooter M., Pattyn P., Peeters M.), the Belgian Society of Gastro-intestinal Endoscopy (Buset M.). Are also represented: the Belgian Professional Surgical Association (Haeck L., Mansvelt B.), the Private Foundation Belgian Cancer Registry (Van Eycken E.). Penninckx F. chairs the PROCARE Workgroup.
,
N. Tinton The PROCARE working group consists of delegates from all Belgian scientific organisations involved in the treatment of rectum cancer, i.e. the Belgian Section of Colorectal Surgery, a section of the Royal Belgian Society of Surgery (De Coninck D., Duinslaeger M., Kartheuser A., Penninckx F., Van de Stadt J., Vaneerdeweg W.), the Belgian Society of Surgical Oncology (Claeys D.), the Belgian Group for Endoscopic Surgery (Burnon D.), the Belgian Society of Radiotherapy — Oncology (Haustermans K., Scalliet P., Spaas Ph.), the Belgian Society of Pathology and the Digestive Pathology Club (Ectors N., Jouret A.), the Belgian Society of Medical Oncology (Bleiberg H., Humblet Y., Van Cutsem E.), the Belgian Group for Digestive Oncology (Laurent S., Van Cutsem E., Van Laethem J. L.), the Royal Belgian Society of Radiology (Op de Beeck B., Danse E.), the Société Royale Belge de Gastro-entérologie (Melange M., Rahier J.), the Vlaamse Vereniging voor Gastro-enterologie (Cabooter M., Pattyn P., Peeters M.), the Belgian Society of Gastro-intestinal Endoscopy (Buset M.). Are also represented: the Belgian Professional Surgical Association (Haeck L., Mansvelt B.), the Private Foundation Belgian Cancer Registry (Van Eycken E.). Penninckx F. chairs the PROCARE Workgroup.
& on behalf of the PROCARE working groupa show all
Pages 149-157 | Published online: 11 Mar 2016

References

  • MacFarlane J. K., Ryall R. D., Heald R. J. Mesorectal excision for rectal cancer. Lancet, 1993, 341: 457–460.
  • Parks A. G., Percy J. P. Resection and sutured colo-anal anastomosis for rectal carcinoma. Br J Surg, 1982, 69: 301–4.
  • Lazorthes F., Fages P., Chiotasso P., Lemozy J., Bloom E. Resection of the rectum with construction of a colonic reservoir and colo-anal anastomosis for carcinoma of the rectum. Br J Surg, 1986, 73: 136–8.
  • Parc R., Tiret E., Frileux P., Moszkowski E., Loygue J. Resection and colo-anal anastomosis with colonic reservoir for rectal carcinoma. Br J Surg, 1986, 73: 139–41.
  • Z’graggen K., Maurer C. A., Buchler M. W. Transverse colo-plasty pouch. A novel neorectal reservoir. Dig Surg, 1999, 16: 363–6.
  • Swedish Rectal Cancer Trial. Improved survival with pre-operative radiotherapy in resectable rectal cancer. N Engl J Med, 1997, 336: 980–7.
  • Kapiteijn E., Marijnen C. A. M., Nagtegaal I. D., Putter H., Steup W.H., Wiggers T., Rutten H. J. T., Pahlman L., Glimelius B., van Krieken J. H. J. M., Leer J. W. H., van de Velde C. J. H., the Dutch Colorectal Cancer Group. Pre-operative radiotherapy combined with total mesorectal excision for resectable rectal cancer. New Engl J Med, 2001, 345: 638–646.
  • Sauer R., Becker H., Hohenberger W., Rödel C., Wittekind C., Fietkau R., Martus P., Tschmelitsch J., Hager E., Hess C. F., Karstens J. H., Liersch T., Schmidberger H., Raab R., for the German Rectal Cancer Study Group. Pre-operative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med, 2004, 351: 1731–40.
  • Quirke P., Durdey P., Dixon M. F., Williams N. S. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet, 1986, 2, 996–9.
  • Nagtegaal I. D., van de Velde C. J. H., van der Worp E., Kapiteijn E., Quirke P., van Krieken H. J. M., and the Pathology Review Committee for the Co-operative Clinical Investigators of the Dutch Colorectal Cancer Group. Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. J Clin Oncol, 2002, 20: 1729–34.
  • Beets-Tan R. G., Beets G. L., Vliegen R. F., Kessels A. G., Van Boven H., De Bruine A., von Meyenfeldt M. F., Baeten C. G., van Engelshoven J. M. Accuracy of magnetic resonance imaging in the prediction of a tumour-free resection margin in rectal cancer surgery. Lancet, 2001, 357: 497–504.
  • Brown G., Radcliffe A. G., Newcombe R. G., Dallimore N. S., Bourne M. W., Williams G. T. Pre-operative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imaging. Br J Surg, 2003, 90: 355–64.
  • Tournigand C., André T., Achille E., Lledo G., Flesh M., Mery-Mignard D., Quinaux E., Couteau C., Buyse M., Ganem G., Landi B., Colin P., Louvet C., de Gramont A. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol, 2004, 22: 229–37.
  • Goldberg R. M., Sargent D. J., Morton R. F., Fuchs C. S., Ramanathan R. K., Williamson S. K., Findlay B. P., Pitot H. C., Alberts S. R. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol, 2004, 22: 23–30.
  • André T., Boni C., Mounedji-Boudiaf L., Navarro M., Tabernero J., Hickish T., Topham C., Zaninelli M., Clingan P., Bridgewater J., Tabah-Fisch I., de Gramont A., for the multicentre international study of oxaliplatin/5-fluorouracil/leu-covorin in the adjuvant treatment of colon cancer (MOSAIC) investigators. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. NEngl J Med, 2004, 350: 234351.
  • Hurwitz H., Fehrenbacher L., Novotny W., Cartwright T., Hainsworth J., Heim W., Berlin J., Baron A., Griffing S., Holmgren E., Ferrara N., Fyfe G., Rogers B., Ross R., Kabbinavar F. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med, 2004, 350: 2335–42.
  • Van Cutsem E. J., Oliveira J., Kataja v. v., ESMO Guidelines Task Force. ESMO minimum clinical recommendations for the diagnosis, treatment and follow-up of advanced colorectal cancer. Ann Oncol, 2005, 16 Suppl 1: i18–9.
  • Hermanek P. The impact of the surgeon’s technique on outcome after treatment of rectal carcinoma. Dis Colon Rectum, 1999, 42: 559–62.
  • Martling A., Cedermark B., Johansson H., Rutqvist L. E., Holm T. The surgeon as a prognostic factor after the introduction of total mesorectal excision in the treatment of rectal cancer. Br J Surg, 2002, 89: 1008–13.
  • Harling H., Bülow S., Moller L. N., Jorgensen T., the Danish Colorectal Cancer Group. Hospital volume and outcome of rectal cancer surgery in Denmark, 1994–99. Colorectal Disease, 2005, 7: 90–95.
  • Wibe A., Eriksen M. T., Syse A., Tretli S., Myrvold H. E., Soreide O., Norwegian Rectal Cancer Group. The effect of hospital caseload on long-term outcome after standardization of rectal cancer surgery at a national level. Br J Surg, 2005, 92: 217–24.
  • Kapiteijn E., Putter H., van de Velde C. J. H., and co-operative investigators of the Dutch Colorectal Cancer Group. The impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in the Netherlands. Br J Surg, 2002, 89: 1142–49.
  • Engel A. F., Oomen J. L. T., Eijsbouts Q. A. J., Cuesta M. A., van de Velde C. J. H. Nationwide decline in annual numbers of abdomino-perineal resections: the effect of a successful national trial ? Colorectal Disease, 2003, 5: 180–4.
  • Martling A. L., Holm T., Rutqvist L. E., Moran B. J., Heald R. J., Cedermark B., for the Stockholm Colorectal Cancer Study Group and the Basingstoke Bowel Cancer Research Project. The effect of a surgical training programme on outcome of rectal cancer in the county of Stockholm. Lancet, 2000, 356: 93–6.
  • Martling A., Holm T., Rutqvist L. E., Johansson H., Moran B., Heald R. J., Cedermark B. The impact of a surgical training programme on rectal cancer outcomes in Stockholm. Br J Surg, 2005, 92: 225–9.
  • Wibe A., Moller B., Norstein J., Carlsen E., Wiig J. N., Heald R. J., Langmark F., Myrvold H. E., Soreide O., for the Norwegian Rectal Cancer Group. A national strategic change in treatment policy for rectal cancer — implementation of total mesorectal excision as routine treatment in Norway. A national audit. Dis Colon Rectum, 2002, 45: 857–866.
  • Wibe A., Eriksen M. T., Syse A., Myrvold H. E., Soreide O., on behalf of the Norwegian Rectal Cancer Group. Total mesorectal excision for rectal cancer — what can be achieved by a national audit ? Colorectal Disease, 2003, 5: 471–477.
  • Pahlman L., Karlbom U. Teaching efforts to spread TME surgery in Sweden. Recent Results Cancer Res, 2005, 165: 82–85.
  • PROCARE multidisciplinary guidelines for the treatment of rectal cancer. www.belsurg.org/imgupload/BSCRS_/PR0CARE%20 GUIDELINES%20printversie82005.pdf.
  • Hermanek P., Sobin L. H. eds. TNM classification of malignant tumours. Fourth edition, 2nd revision, Berlin Springer-Verlag: 1992.
  • Belgium, Life tables 1997–1998, “Federal Public Service Economy, SMEs, Self-employed and Energy, Directorate-general Statistics Belgium, Service Demography”.
  • NIH Consensus Conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA, 1990, 264: 1444–50.
  • Scheiden K., Sand J., Weber J., Turk P., Wagener Y., Capesius C. Rectal cancer in Luxembourg: a national population-based data report, 1988–1998. BMC Cancer, 2003, 3: 27–35.
  • Iversen L. H., Pedersen L., Riis A., Friis S., Laurberg S., Sorensen H. T. A population-based study of short-and long-term survival from colorectal cancer in Denmark 1977–1999. Br J Surg, 2005, 92: 873–880.
  • Kerr J., Engel J., Eckel R., Hölzel D. Survival for rectal cancer patients and international comparisons. Ann Oncol, 2005, 16: 664–672.
  • van de Velde C. on behalf of the Dutch Colorectal Cancer Group. Personal communication.
  • Wlbe A. on behalf of the Norwegian Rectal Cancer Group. Personal communication.
  • Sauer R. on behalf of the German Rectal Cancer Study Group. Personal communication.
  • Gerard J. P., Bonnetain F., Conroy T., Chapet O., Bouche O., Closon-Dejardin M. T., Untereiner M., Leduc B., Francois E., Bedenne L. Pre-operative radiotherapy ± 5 FU/folinic acid in T3-4 rectal cancers: results of the FFCD 9203 randomized trial. J Clin Oncol, 2005, 16S: 3504.
  • Bosset J. F., Calais G., Mineur L., Maingon P., Radosevic-Jelic L., Daban A., Bardet E., Beny A., Ollier J. C., Collette L. Pre-operative radiation in rectal cancer: the effect and timing of additional chemotherapy, 5-year results of the EORTC 22921 trial. J Clin Oncol, 2005, 16S: 3505.
  • Beauduin M., Deneufbourg J. M., De Neve W., Hermans J., Hoornaert M. T., Scalliet P., Spaas P., Vanderick J., Van Dijcke M., Van Houtte P., Vynckier S., Weltens C. The management of rectal cancer in Belgium: a survey of our practice. Acta Gastro enterol Belg, 2004, 67: 9–13.
  • Haeck L. Het PROCARE project. De Geneesheer-Specialist, November, 2004, p. 6.
  • Holm T., Johansson H., Cedermark B., Ekelund G., Rutqvist L. E. Influence of hospital-and surgeon-related factors on outcome after treatment of rectal cancer with or without preoperative radiotherapy. Br J Surg, 1997, 84: 657–63.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.